From April 8 to 12, 2024, the 2024 Wuzhen Health Conference was held in Wuzhen with the spirit of "Creating a Better Future" and the theme of "Resilience and Change". The conference specially set up the "West Lake Award • Outstanding Person Award in China's Pharmaceutical Industry" to set an example for the industry and applaud the strivers. Li Kun, CEO of Zhendong Group, was awarded this honor. After entering the health industry, Li Kun's leadership and innovative spirit have injected a strong impetus into the rapid development of Zhendong Pharmaceutical in the health industry. Under his leadership, Zhendong Pharmaceutical has continuously launched innovative products to meet the needs of patients and improve service quality, which has won market recognition and praise.
Winning the "West Lake Award • Outstanding Person Award in China's Pharmaceutical Industry" is an affirmation of Li Kun's achievements in the field of pharmaceutical industry and a recognition of Zhendong Group's contribution in the field of health industry. This will provide a stronger impetus for Zhendong Group to develop in the future and motivate them to make greater contributions to the cause of human health. At the recent West Lake Forum, Li Kun talked about the connection between the quality of traditional Chinese medicine and the development of Chinese patent medicine brands.
After the epidemic, the sales of proprietary Chinese medicines have grown steadily, and in recent years, many well-known Chinese medicine brands have come to the fore. The root cause of these brands being able to gain a foothold in the market lies in the quality of their products. The basis of the quality of Chinese medicine is Chinese herbal medicine. The quality of Chinese herbal medicines is affected by many factors, but the most basic and important is the source Chinese herbal medicines. Therefore, all walks of life in the industry are calling for improving the quality of Chinese herbal medicines and ensuring the healthy development of the Chinese medicine industry. Academician Zhang Boli pointed out that high-quality Chinese herbal medicines are an important material guarantee for the high-quality development of traditional Chinese medicine. Academician Chen Shilin also emphasized that the quality of Chinese herbal medicines directly determines the quality of Chinese medicine products and the therapeutic effect of Chinese medicine. Therefore, the quality of Chinese herbal medicines is not only a problem for the development of the Chinese medicine industry, but also an issue related to the health of the people.
Li Kun pointed out that the authenticity of Chinese herbal medicines is the basis of their quality. Authenticity refers to the characteristics of the specific associated environment and climate ecology formed by Chinese herbal medicines under specific geographical location and natural conditions, which have been clinically recognized by traditional Chinese medicine for a long time, and have excellent quality and good effects. In order to build a Chinese medicine brand in the whole process, we need to consolidate the foundation of the Chinese medicine brand from the source. First of all, the debut area was screened, and varieties with many ingredients and high content were selected as Chinese herbal medicine seeds. Then, the experts were jointly formulated to develop the authenticity standards of medicinal materials and develop a standardized base for the provincial area. At the same time, pay attention to the initial processing of the production area, pay attention to the pre-treatment of decoction pieces, and standardize the storage according to the different characteristics of medicinal materials.
The processing of Chinese medicines is an important part of improving the quality of Chinese herbal medicines, and the industry should be encouraged to use the processed decoction pieces. The new version of the GAP specification requires traditional Chinese medicine manufacturers to give priority to the use of standardized medicinal materials, and there are clear requirements for the use of standardized medicinal materials in drug approval documents. In response to the requirements of the state, the production and use of decoction pieces are carried out in accordance with the "National Specifications for the Processing of Traditional Chinese Medicine Decoction Pieces". At the same time, modern intelligent technology is scientifically used to control the quality of traditional Chinese medicine in the whole production process. Zhendong Group can set up 362 quality control points and establish 260 standard operating procedures in the production process automation control system. In addition, according to the different types of proprietary Chinese medicines, the storage and transportation are standardized according to standards. For example, capsules, tinctures, and medicinal liquor are easy to soften and volatilize when the temperature is too high, granules and powders are easy to bond and agglomerate when the humidity is too high, and patches are easy to lose their viscosity when the humidity is too low.
All indications show that the quality of Chinese herbal medicines is the cornerstone of the development of Chinese patent medicine brands. Only by controlling the quality of Chinese herbal medicines from the source and strictly controlling the whole process can we ensure the quality and effect of Chinese patent medicine brands, and then promote the healthy development of the Chinese medicine industry. Li Kun knows that professionalism is the cornerstone of pharmaceutical enterprises. As a result, he draws on his expertise and experience to create new strategies that adapt to market changes. He understands that new products are the key to attracting users, so he grasps the development of new products and constantly develops new user groups. At the same time, he did not forget to take the reform as an opportunity to expand new sales channels, and to serve as a guarantee to open up a new market world. Under Li Kun's continuous cultivation, Zhendong Group has not only made steady progress in the health industry, but also achieved remarkable results in promoting system reform, systematically sorting out products, and promoting online and offline market activities. His leadership and innovative spirit have injected strong impetus into the rapid development of Zhendong Pharmaceutical in the health industry.
Li Kun's achievements have not only been recognized by the industry, but also won the "West Lake Award • Outstanding Person Award in China's Pharmaceutical Industry" at the 2024 Wuzhen Health Conference, which is an affirmation of his achievements in the field of pharmaceutical industry and a recognition of Zhendong Pharmaceutical's contribution in the field of health industry. Looking forward to the future, we have reason to believe that under the leadership of Li Kun, Zhendong Pharmaceutical will continue to uphold the spirit of "creating a better world together" and inject new vitality into the development of the health industry with the attitude of "resilience and change". They will make greater contributions to the cause of human health with high-quality products and services, and jointly write a brilliant chapter in the health industry.